These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34972158)

  • 41. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
    van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.
    Uhl M; Kepp O; Jusforgues-Saklani H; Vicencio JM; Kroemer G; Albert ML
    Cell Death Differ; 2009 Jul; 16(7):991-1005. PubMed ID: 19229247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway.
    Bagai R; Valujskikh A; Canaday DH; Bailey E; Lalli PN; Harding CV; Heeger PS
    J Immunol; 2005 Jun; 174(12):7711-5. PubMed ID: 15944272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
    Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
    Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-dressing: an alternative mechanism for antigen presentation.
    Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
    Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and -presentation by B lymphocytes.
    Tobian AA; Harding CV; Canaday DH
    J Immunol; 2005 May; 174(9):5209-14. PubMed ID: 15843516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.
    Ma W; Zhang Y; Vigneron N; Stroobant V; Thielemans K; van der Bruggen P; Van den Eynde BJ
    J Immunol; 2016 Feb; 196(4):1711-20. PubMed ID: 26792804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.
    François M; Romieu-Mourez R; Stock-Martineau S; Boivin MN; Bramson JL; Galipeau J
    Blood; 2009 Sep; 114(13):2632-8. PubMed ID: 19654411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain.
    Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA
    Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.
    Wang X; Li H; Matte-Martone C; Cui W; Li N; Tan HS; Roopenian D; Shlomchik WD
    Blood; 2011 Dec; 118(24):6426-37. PubMed ID: 21963602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells.
    Fiegl D; Kägebein D; Liebler-Tenorio EM; Weisser T; Sens M; Gutjahr M; Knittler MR
    J Immunol; 2013 Mar; 190(6):2791-806. PubMed ID: 23418629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.
    Sacha JB; Reynolds MR; Buechler MB; Chung C; Jonas AK; Wallace LT; Weiler AM; Lee W; Piaskowski SM; Soma T; Friedrich TC; Wilson NA; Watkins DI
    J Virol; 2008 Sep; 82(18):9293-8. PubMed ID: 18596093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A CD74-dependent MHC class I endolysosomal cross-presentation pathway.
    Basha G; Omilusik K; Chavez-Steenbock A; Reinicke AT; Lack N; Choi KB; Jefferies WA
    Nat Immunol; 2012 Feb; 13(3):237-45. PubMed ID: 22306692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.
    Johnstone C; Ramos M; García-Barreno B; López D; Melero JA; Del Val M
    Immunol Cell Biol; 2012 Nov; 90(10):978-82. PubMed ID: 22929180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
    Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
    J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.